慢性乙型肝炎的三联疗法、中医免疫辨证三环治疗观察(1)
 |
| 第1页 |
参见附件(3020KB，3页)。
[摘要] 目的：观察三联疗法、中医免疫辨证三环治疗慢性乙型肝炎的临床疗效。方法：将我院2009年1～12月收治的96例慢性乙型肝炎患者随机分为观察组和对照组。观察组48例患者采用三联疗法、中医免疫辨证三环治疗，对照组48例患者采用传统药物治疗，对比两组的临床疗效。结果：对照组总有效率为77.08%，观察组总有效率为91.67%，观察组疗效显著优于对照组，两组比较差异有高度统计学意义(P<0.01)。结论：三联疗法、中医免疫辨证三环治疗慢性乙型肝炎具有疗效确切、副作用小以及不易反复的优势，建议在慢性乙型肝炎的临床治疗中广泛推广应用。
[关键词] 慢性乙型肝炎；三联疗法；中医免疫辨证三环治疗
[中图分类号] R512.62 [文献标识码] A [文章编号] 1673-7210(2011)07(a)-100-02
The observation on triple therapy and triple ring of TCM immune discrimination in the treatment of chronic hepatitis B
ZENG Guolu
Department of Traditional Chinese Medicine, Xixiang People's Hospital of Bao'an District in Shenzhen City, Guangdong Province, Shenzhen 518101, China
[Abstract] Objective: To observe the clinical efficacy on triple therapy and triple ring of TCM immune discrimination in the treatment of chronic hepatitis B. Methods: 96 patients with chronic hepatitis B in our hospital from January 2009 to December 2009 were divided randomly into two groups, 48 patients in the observation group were given triple therapy and triple ring of TCM immune discrimination, 48 patients in the control group were given traditional medicine therapy, and the clinical efficacy of the two groups were compared. Results: The total efficiency of the control group was 77.08%, the observation group was 91.67%, the observation group was significantly better than that of the control group (P<0.01). Conclusion: Triple therapy and triple ring of TCM immune discrimination in the treatment of chronic hepatitis B have a great strength with definite effect, small side effects and difficult to repeat, it is worthy to use in the clinical treatment of chronic hepatitis B.
[Key words] Chronic hepatitis B; Triple therapy; Triple ring of TCM immune discrimination
慢性乙型肝炎在临床中属于一种常见的肝部疾病，中医认为是自身正气不足、感受邪毒、日久肝气郁结、气滞血瘀、肝肾不足所致[1]。我院将三联疗法、中医免疫辨证三环治疗方法引入到慢性乙型肝炎的临床中来，取得了令人满意的临床疗效，具体报道如下：
1 资料与方法
1.1 一般资料
选择我院2009年1～12月收治的96例慢性乙型肝炎患者，将其随机分为观察组(48例)和对照组(48例)，所有患者经诊断均符合《2009乙肝防治指南》。观察组男31例，女17例；年龄21～61岁，平均(46.85±23.67)岁；病程1～15年，平均(8.87±7.69)年；依据2000年《病毒性肝炎防治方案》分型：慢性乙型肝炎免疫介入轻度8例，中度13例，重度27例。对照组男29例，女19例；年龄18～57岁，平均(45 ......
您现在查看是摘要介绍页，详见PDF附件(3020KB，3页)。